Skip to main content

FDA recall, , Moderate risk

Beckman Coulter MicroScan Neg MIC 56 Panels

MicroScan panels may be contaminated in some wells.

What happened

Beckman Coulter, Inc., of West Sacramento, California, recalled MicroScan Neg MIC 56 REF C42464 panels because of the likely presence of contamination in well(s). The recall began July 24, 2025, and was added to the FDA's Enforcement Report on March 20, 2026. The panels are designed for use in determining antimicrobial agent susceptibility and/or identification to the species level of aerobic and facultatively anaerobic gram-negative bacilli.

The recalled product was distributed in California, Colorado, Indiana, Massachusetts, Maryland, Minnesota, Missouri, North Carolina, New Jersey, Oklahoma, Pennsylvania, and Texas.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the UDI-DI and lot code listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. MicroScan Neg MIC 56 REF C42464 UDI-DI code: 15099590731212 MicroScan panels

    UDI-DI
    • 15099590731212
    Lot code
    • 2026-01-03

Recall details

Company began the recall
Sold in

U.S. Nationwide distribution in the states of California, Colorado, Indiana, Massachusetts, Maryland, Minnesota, Missouri, North Carolina, New Jersey, Oklahoma, Pennsylvania, and Texas.

Company
Beckman Coulter, Inc.West Sacramento, California
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98555
Recall number
Z-1609-2026
Quantity recalled
685 boxes

All recalls from Beckman Coulter, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)